Marta Ribeiro started the topic Ocrevus Use Rises for New RRMS Patients, Drops Among PPMS Patients in the forum MS Medications 3 years, 1 month ago
Overall, first-line use of Genentech’s Ocrevus for MS patients has remained stable through 2019 compared to 2018, according to Spherix Global Insights. Read more here.
What do you think of this information?
Marta Ribeiro changed their profile picture 4 years, 11 months ago